209 related articles for article (PubMed ID: 8091320)
1. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream").
Newnham DM; Lipworth BJ
Thorax; 1994 Aug; 49(8):762-70. PubMed ID: 8091320
[TBL] [Abstract][Full Text] [Related]
2. Effects of airway calibre on lung delivery of nebulised salbutamol.
Lipworth BJ; Clark DJ
Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery in asthma: a comparison of spacers with a jet nebuliser.
Gibson PG; Wlodarczyk JH; Borgas T
Aust N Z J Med; 1995 Aug; 25(4):324-9. PubMed ID: 8540873
[TBL] [Abstract][Full Text] [Related]
4. Improvement of nebulised antibiotic delivery in cystic fibrosis.
Wilson D; Burniston M; Moya E; Parkin A; Smye S; Robinson P; Littlewood J
Arch Dis Child; 1999 Apr; 80(4):348-52. PubMed ID: 10086942
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.
Lipworth BJ; Newnham DM; Clark RA; Dhillon DP; Winter JH; McDevitt DG
Thorax; 1995 Jan; 50(1):54-61. PubMed ID: 7886650
[TBL] [Abstract][Full Text] [Related]
6. Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizer.
Lipworth BJ; Clark DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):160-3. PubMed ID: 9491830
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution.
Zainudin BM; Biddiscombe M; Tolfree SE; Short M; Spiro SG
Thorax; 1990 Jun; 45(6):469-73. PubMed ID: 2392793
[TBL] [Abstract][Full Text] [Related]
8. Nebuliser systems for drug delivery in cystic fibrosis.
Daniels T; Mills N; Whitaker P
Cochrane Database Syst Rev; 2013 Apr; (4):CD007639. PubMed ID: 23633344
[TBL] [Abstract][Full Text] [Related]
9. Intravenous beta agonist in severe acute asthma.
Cheong B; Reynolds SR; Rajan G; Ward MJ
BMJ; 1988 Aug; 297(6646):448-50. PubMed ID: 3139138
[TBL] [Abstract][Full Text] [Related]
10. An in vitro analysis of the output of salbutamol from different nebulizers.
Barry PW; O'Callaghan C
Eur Respir J; 1999 May; 13(5):1164-9. PubMed ID: 10414421
[TBL] [Abstract][Full Text] [Related]
11. Randomised crossover trial of salbutamol aerosol delivered by metered dose inhaler, jet nebuliser, and ultrasonic nebuliser in chronic lung disease.
Fok TF; Lam K; Ng PC; So HK; Cheung KL; Wong W; So KW
Arch Dis Child Fetal Neonatal Ed; 1998 Sep; 79(2):F100-4. PubMed ID: 9828734
[TBL] [Abstract][Full Text] [Related]
12. Influence of breathing pattern on lung deposition and bronchodilator response to nebulised salbutamol in patients with stable asthma.
Zainudin BM; Tolfree SE; Short M; Spiro SG
Thorax; 1988 Dec; 43(12):987-91. PubMed ID: 3238642
[TBL] [Abstract][Full Text] [Related]
13. Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask.
Parkes SN; Bersten AD
Thorax; 1997 Feb; 52(2):171-5. PubMed ID: 9059480
[TBL] [Abstract][Full Text] [Related]
14. Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma.
Mitchell DM; Solomon MA; Tolfree SE; Short M; Spiro SG
Thorax; 1987 Jun; 42(6):457-61. PubMed ID: 3660305
[TBL] [Abstract][Full Text] [Related]
15. Enhanced delivery of nebulised salbutamol during non-invasive ventilation.
Calvert LD; Jackson JM; White JA; Barry PW; Kinnear WJ; O'Callaghan C
J Pharm Pharmacol; 2006 Nov; 58(11):1553-7. PubMed ID: 17132219
[TBL] [Abstract][Full Text] [Related]
16. Holding chambers versus nebulisers for inhaled steroids in chronic asthma.
Cates CJ; Adams N; Bestall J
Cochrane Database Syst Rev; 2001; (2):CD001491. PubMed ID: 11405994
[TBL] [Abstract][Full Text] [Related]
17. [Drug Output and Aerosol Characteristics of Different Jet Nebulisers for Adults While Simulating the Nebulisation of Salbutamol].
Walz-Jung H; Krämer I; Kamin W
Pneumologie; 2018 Dec; 72(12):820-831. PubMed ID: 30453377
[TBL] [Abstract][Full Text] [Related]
18. Reversibility tests in chronic obstructive airways disease: their predictive value with reference to benefit from domiciliary nebuliser therapy.
Teale C; Morrison JF; Jones PC; Muers MF
Respir Med; 1991 Jul; 85(4):281-4. PubMed ID: 1835110
[TBL] [Abstract][Full Text] [Related]
19. Nebulised adrenaline in acute severe asthma: comparison with salbutamol.
Coupe MO; Guly U; Brown E; Barnes PJ
Eur J Respir Dis; 1987 Oct; 71(4):227-32. PubMed ID: 3691679
[TBL] [Abstract][Full Text] [Related]
20. The use of water as a diluent for bronchodilator nebuliser solutions.
Kwong T; Town I; Windom H; Beasley R
N Z Med J; 1990 Jun; 103(892):290-1. PubMed ID: 2366999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
